Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 17, 2026 22:46 ET | Source: CytomX Therapeutics Inc.

CytomX Therapeutics Announces Pricing of $250 Million Offering of Common Stock and Pre-Funded Warrants

SOUTH SAN FRANCISCO, Calif., March 17, 2026 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a leader in the field of masked, conditionally activated biologics, today announced the...
March 17, 2026 22:46 ET | Source: SAB Biotherapeutics, Inc.

SAB BIO Announces Pricing of $85 Million Public Offering of Common Stock and Pre-Funded Warrants

MIAMI, March 17, 2026 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte immunoglobulin (hATG) for type...
March 17, 2026 20:00 ET | Source: Lantronix, Inc.

Lantronix to Showcase Intelligent PoE Infrastructure and Edge AI Solutions for Autonomous Systems at ISC West 2026

IRVINE, Calif., March 17, 2026 (GLOBE NEWSWIRE) -- Lantronix Inc. (Nasdaq: LTRX), a global provider of Edge AI and Industrial IoT solutions that power NDAA-compliant unmanned systems, critical...
March 17, 2026 20:00 ET | Source: ASCENTAGE PHARMA GROUP INTERNATIONAL

Ascentage Pharma to Present Data From Four Preclinical Studies In Its Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 2026

ROCKVILLE, Md. and SUZHOU, China, March 17, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company...
March 17, 2026 19:19 ET | Source: Mesoblast Limited

Mesoblast to Host R&D Day on April 8, 2026

NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, will host its inaugural R&D Day...
March 17, 2026 19:14 ET | Source: ZenaTech Inc.

ZenaTech desarrolla un dron interceptor autónomo de bajo costo y de un solo uso para el sistema Counter-UAS de ZenaDrone para uso en defensa de EE. UU., Medio Oriente y Ucrania

VANCOUVER, Columbia Británica, March 17, 2026 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), proveedor de soluciones tecnológicas especializado en drones...
March 17, 2026 18:45 ET | Source: The RealReal

The RealReal to Participate in Fireside Chat at the 38th Annual Roth Conference

SAN FRANCISCO, March 17, 2026 (GLOBE NEWSWIRE) -- The RealReal (Nasdaq: REAL)—the world’s largest online marketplace for authenticated, resale luxury goods—today announced that Ajay Gopal, the...
March 17, 2026 18:45 ET | Source: Gemini Space Station, Inc.

Gemini Updates Timing of Fourth Quarter and Full Year 2025 Results Conference Call

NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Gemini Space Station, Inc. (“Gemini”) (NASDAQ: GEMI), a global crypto and prediction markets platform, today announced an update to the timing of its...
March 17, 2026 18:37 ET | Source: Revolution Medicines, Inc.

Revolution Medicines to Showcase Progress Across RAS(ON) Targeted Oncology Pipeline with Multiple Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting

REDWOOD CITY, Calif., March 17, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq:RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted...
March 17, 2026 18:00 ET | Source: Qfin Holdings, Inc.

Qfin Holdings Announces Fourth Quarter and Full Year 2025 Unaudited Financial Results and Raises Semi-Annual Dividend

SHANGHAI, China, March 17, 2026 (GLOBE NEWSWIRE) -- Qfin Holdings, Inc. (NASDAQ: QFIN; HKEx: 3660) (“Qfin Holdings” or the “Company”), a leading AI-empowered Credit-Tech platform in China, today...